The Patent Finder

Terms ending in 2039

Genentech, Inc.

Every in-force patent on Genentech, Inc.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US D1,009,935Display Screen or Portion Thereof with Graphical User Interface
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 11,674,962Therapeutic and Diagnostic Methods for Cancer
In force
 · High confidence
Foundation Medicine, Inc.In forceHigh confidence
US 11,473,151Diagnostic and Therapeutic Methods for Cancer
In force
 · Low confidence
Genentech, Inc.In forceLow confidence
US 12,624,098Treatment of Age-Related Macular Degeneration and Diabetic Macular Edema by Administration of a Bispecific Antibody to VEGF and ANG-2
In force
 · Medium confidence
Hoffmann-La Roche Inc.In forceMedium confidence
US 11,485,975Oligonucleotides for Modulating TMEM106B Expression
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 12,297,270Bispecific Antigen-Binding Molecules and Methods of Use
In force
 · Medium confidence
Genentech, Inc.In forceMedium confidence
US 11,513,127Methods for Assaying T-Cell Dependent Bispecific Antibodies
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 11,834,461Bicyclic Ketone Compounds and Methods of Use Thereof
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 11,028,075Therapeutic Compounds and Methods of Use Thereof
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 11,076,984Method of Performing Subretinal Drainage and Agent Delivery
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
35 more term ends in 2039 · Pro
10 of 45 patents shown. Soonest term end first, then patent number.
Pro members see all 45.
Upgrade to Pro
33 of these are in force and held by Genentech, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited